User profiles for D. Bilton

David T Bilton

Professor of Aquatic Biology, University of Plymouth; Visiting Professor, University of …
Verified email at plymouth.ac.uk
Cited by 9015

British thoracic Society guideline for non-CFbronchiectasis

MC Pasteur, D Bilton, AT Hill - Thorax, 2010 - thorax.bmj.com
The diagnosis, investigation and particularly management of bronchiectasis has been
largely empirical and the subject of relatively few controlled clinical trials. There are no clear …

Dispersal in freshwater invertebrates

DT Bilton, JR Freeland… - Annual review of ecology …, 2001 - annualreviews.org
▪ Abstract Movement between discrete habitat patches can present significant challenges to
organisms. Freshwater invertebrates achieve dispersal using a variety of mechanisms that …

[HTML][HTML] Lung clearance index: evidence for use in clinical trials in cystic fibrosis

…, JM Bradley, K Bayfield, K O'Neill, D Savi, D Bilton… - Journal of Cystic …, 2014 - Elsevier
The ECFS-CTN Standardisation Committee has undertaken this review of lung clearance
index as part of the group's work on evaluation of clinical endpoints with regard to their use in …

An investigation into causative factors in patients with bronchiectasis

…, RA Coulden, CD Flower, D Bilton… - American journal of …, 2000 - atsjournals.org
Bronchiectasis is a pathologic description of lung damage characterized by inflamed and
dilated thick-walled bronchi. These findings may result from a number of possible causes and …

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

…, LD Knibbs, L Morawska, PD Sly, A Jones, D Bilton… - Science, 2016 - science.org
Lung infections with Mycobacterium abscessus, a species of multidrug-resistant nontuberculous
mycobacteria, are emerging as an important global threat to individuals with cystic …

[HTML][HTML] Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

…, D Ashby, KJ Bayfield, D Bilton… - The Lancet …, 2015 - thelancet.com
Background Lung delivery of plasmid DNA encoding the CFTR gene complexed with a
cationic liposome is a potential treatment option for patients with cystic fibrosis. We aimed to …

[HTML][HTML] Recommendations for the classification of diseases as CFTR-related disorders

…, M Tzetis, M Wilschanski, C Bareil, D Bilton… - Journal of Cystic …, 2011 - Elsevier
Several diseases have been clinically or genetically related to cystic fibrosis (CF), but a
consensus definition is lacking. Here, we present a proposal for consensus guidelines on cystic …

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in …

…, CL Daley, JL Herrmann, JA Nick, PG Noone, D Bilton… - Thorax, 2016 - thorax.bmj.com
… However, interventional trials of vitamin D supplementation in patients with active pulmonary
TB have had mixed results,183 and there are no trials of vitamin D as an adjuvant treatment …

The effect of geographical scale of sampling on DNA barcoding

J Bergsten, DT Bilton, T Fujisawa, M Elliott… - Systematic …, 2012 - academic.oup.com
Eight years after DNA barcoding was formally proposed on a large scale, CO1 sequences
are rapidly accumulating from around the world. While studies to date have mostly targeted …

Mediterranean Europe as an area of endemism for small mammals rather than a source for northwards postglacial colonization

DT Bilton, PM Mirol, S Mascheretti… - … of the Royal …, 1998 - royalsocietypublishing.org
… Incomplete sequence data from two additional pygmy shrews from the same locality in
central Italy (DT Bilton, unpublished data) indicate that they also had all seven unique …